• 제목/요약/키워드: Cyclosporine(CsA)

검색결과 41건 처리시간 0.025초

흰쥐에서 Cyclosporine의 약동학적 지표에 대한 Nicardipine의 영향 (Effect of Nicardipine on the Pharmacokinetic Parameters of Cyclosporine in Rat)

  • 김희규;강주섭;이창호;신인철
    • Biomolecules & Therapeutics
    • /
    • 제6권4호
    • /
    • pp.389-394
    • /
    • 1998
  • Cyclosporine (CsA) is a major immunosuppressive drug used widely to prevent organ allograft rejection. fits potential organotoxicity by prolonged use is known to cause both direct tissue damage and indirect pharmacokinetic interactions with other drugs. This study was performed to determine the effect of nicardipine (NCP) on the pharmacokinetic parameters of CsA in Sprague-Dawley rats. Each rat was administered with CsA in saline-treated group or in NCP-treated group which was pretreated with NCP (5 mg/kg/12 hours, i.p.) for 6 days. The plasma CsA concentration were analyzed by reversed HPLC: UV system at 0.5, 1, 2, 4, 6, and 8 hours after bolus injection of CsA (10 mg/kg). Pharmacokinetic parameters (mean$\pm$ SD, n=7) such as initial plasma concentration (C(0)), mean residence time (MRT), steady-state volume of distribution (Vdss), terminal half-life (t$\frac{1}{2}$($\beta$)) and plasma clearance (CLp) of CsA in each groups (saline-group vs NCP-group) were determined as follows: C(0) (5.66$\pm$ 1.98 vs 17.98$\pm$2.36, p<0.01); Vdss (2.68$\pm$ 1.6 vs 0.94 $\pm$ 0.25, p<0.01); CLp (0.53 $\pm$0.18 vs 0.21 $\pm$0.06, p<0.01). Therefore, Our results indicate that nicardipine significantly affects the pharmacokinetic parameters of cyclosporme, especially C(0), Vdss, and CLp in NCP-treated group. We suggest that the significant pharmacokinetic interaction between cyclosporine and nicardipine should be considered and cyclosporine level should be closely monitored and dosage reduction made as necessary in clinical situation that was coadministered with CsA and NCP.

  • PDF

Sprague-Dawley계 정상흰쥐에서 포도당 내성과 인슐린 감수성에 대한 Cyclosporine의 영향 (Effects of Cyclosporine on Glucose Tolerance and Insulin Sensitivity in Sprague-Dawley Rats)

  • 강주섭;고현철;이창호;신인철;김동선;양석철;전용철
    • Biomolecules & Therapeutics
    • /
    • 제7권4호
    • /
    • pp.342-346
    • /
    • 1999
  • This study was performed to investigate the effect of cyclosporine (CsA) on glucose tolerance and peripheral insulin sensitivity in normal Sprague-Dawley rats. After daily treament of CsA (10 mg/kg, i.p.) for two weeks, glucose tolerance tests were carried out by the treatment of glucose (Glu, 2 g/kg, i.p.) alone or in conjunction with exogenous insulin (Ins; human regular insulin, 5 U/kg, s.c.) and measured the decrement of area under the time-plasma glucose concentration curve ($AUC_{o\longrightarrow120}$; g.min/ml) by the trapezoidal rule. The rats were divided into three groups (Glu- (Control), Ins+Glu- and CsA+Ins+Glu-, n=7 in each group). The $AUC_{o\longrightarrow120}$ of the CsA+Ins+Glu-group was significantly (p<0.01) lower than that of Glu-group (61.0% of control) and significantly (p<0.05) higher than that of Ins+Glu-group (197.4% of Ins+Glu-). The CsA+Ins+Glu- grou showed higher levels of maximal blood glucose concentration and higher $AUC_{o\longrightarrow120}$ than those of Ins+Glu-group in normal rats. Besides direct pancreatic toxicity of CsA previously reported (Hahn et al., 1972), these results suggest that CsA also make the possibility to induce peripheral insulin insensitivity and glucose intolerance in normal rats.

  • PDF

Cyclosporine A에 의해 과증식된 치은 조직에서 배양된 섬유아세포의 성장인자 발현에 관한 연구 (THE mRNA EXPRESSION OF GROWTH FACTORS IN FIBROBLAST FROM GINGIVAL HYPERPLASIA INDUCED BY CYCLOSPORINE A)

  • 김영면;황경균;이재선;박창주;심광섭
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제28권5호
    • /
    • pp.445-453
    • /
    • 2006
  • Cyclosporine A (CsA) is a powerful immunosuppresive agent used to prevent graft rejection of organ and treat autoimmune disease. One of the major side effects associated with CsA treatment is the development of gingival overgrowth. The purpose of this study was to investigate the mRNA expression and association of the several growth factors in gingival overgrowth induced by CsA, respectively. Gingival fibroblasts were obtained from gingival tissues of healthy donor and the patients treated with CsA. The cultured gingival fibroblasts were incubated with increasing concentrations of CsA for 24 hours, and the expression of MMP-1, TIMP-1, $TGF-{\beta}_1$, p21 were determined by reverse transcription-polymerase chain reaction (RT-PCR). The expressions of MMP-1 was slightly increased according to the concentration of treated CsA, but there was no statistical significance. TIMP-1 showed the increased expression at the CsA concentration of 250 and 500 ng/ml and significantly decreased at the CsA concentration of 750ng/ml. $TGF-{\beta}_1$ showed the increased expression at the CsA concentration of 500 and 750 ng/ml. The expression of p21 was not changed significantly. We concluded that the gingival hyperplasia induced by CsA was more related with $TGF-{\beta}_1$ than MMP-1 or TIMP-1 on gingival collagen metabolism in patients treated with CsA.

New Analytical Method of Cyclosporine A in Human Serum by High -performance Liquid Chromatography/Diode Array Detector and Its Application to Pharmacokinetics of Cyclosporine A in Human Volunteers

  • Kim, Eun-Young;Chung, Yeon-Bok;Kwon, Oh-Seung
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.423.1-423.1
    • /
    • 2002
  • A simple. specific and sensitive method for the determination of cyclosporine A (CsA) in human serum has been developed by a high performance liquid chromatography/diode array detector (DAD) and applied to pharmacokinetic study of CsA. This method involves the use of solid phase extraction procedure following rapid protein precipitation with zinc sulphate from 1 $m\ell$ of human serum, using a disposable $C_{18}$ extraction cartridge. (omitted)

  • PDF

저염식이를 이용한 cyclosporine 신독성에서 angiotensin converting enzyme Inhibitor의 영향 (The Effect of Angiotensin Converting Enzyme Inhibitor on Chronic Cyclosporine Nephropathy in Salt Depleted Rats)

  • 이은주;이은실;하정희;김용진;박용훈
    • Childhood Kidney Diseases
    • /
    • 제4권2호
    • /
    • pp.127-135
    • /
    • 2000
  • 목 적 : Cyclosporine(CsA)는 면역 억제제로서 중요한 역할을 하고 있지만 가장 중요한 부작용인 신독성 때문에 사용에 제한이 있다. 이에 저염식이를 한 쥐에서 유발되는 만성 CsA 신증에서 angiotensin converting enzyme 억제제(ACEI)가 미치는 영향을 검색하고자 하였다. 대상 및 방법 : 흰 쥐를 대상으로 하여 표준식이(NSD), 저염식이(LSD), NSD+CsA. LSD+CsA, NSD+CsA+ACEI, LSD+CsA+ACEI를 1-6군으로 분류하여 공급하였다. 6주 후 혈중 CsA농도, 혈청 sodium, potassium, GFR을 측정하였고, 신장의 조직검사를 시행하였다. 성 적 : 혈중 CsA농도와 sodium치는 각 군간에 차이가 없었고 potassium치는 CsA 단독 투여시에는 식이군간에 차이가 없었으나, CsA와 ACEI를 병용 투여시에는 NSD군에 비해서 LSD군에서 유의하게 증가하였다. (P<0.05). 사구체 여과율은 CsA만 투여한 경우나 CsA와 ACEI를 병용투여한 경우에서 NSD군에 비해 LSD군에서 유의하게 감소하였고 NSD를 시행한 경우에서는 CsA만 투여한 경우보다 ACEI를 병용투여했을 때 GFR이 더 감소하였다 (P<0.05). 조직학적 소견은 CsA투여에 의한 근위부 세뇨관 위축, 간질의 섬유화와 PAS염색 양성인 과립들이 출현하였고 이는 NSD군보다 LSD군에서 더 저명하였으며 ACEI를 병용시에도 LSD군에서 이러한 변화가 더 저명하게 관찰되었으나 ACEI 투여 전과는 큰 차이를 보이지 않았다. 결 론 : 본 연구에서는 염분 부족은 renin-angiotensin system을 활성화해서 CsA 신증을 더욱 가중시키며, ACEI는 LSD로 유발된 CsA 신증에서 신기능의 화학적 지표와 조직학적으로 더욱 악화시컸다. 이 결과로 LSD로 인해 더욱 조장될 수 있는 간접적인 신허혈 상태에서는 ACEI는 신관류를 개선하지 못하고, 이로 인해 신독성이 더욱 악화될 수 있을 것으로 생각되었다.

  • PDF

저염식으로 유도한 Cyclosporine 신독성 백서에서의 치은 변화 (Comparative Study of Gingival Changes in Cyclosporine-Induced Nephrotoxicity with Normal and Low Salt Diet)

  • 임재계;김용진;박용훈
    • Journal of Periodontal and Implant Science
    • /
    • 제30권2호
    • /
    • pp.359-374
    • /
    • 2000
  • Cyclosporine A(CsA) is a widely used immunosuppressant for transplant patients and is also used for the treatment of a wide variety of systemic diseases with immunologic disorders. However, its use is frequently limited because of complications such as nephrotoxicity or gingival hyperplasia. Although several hypotheses have been postulated for CsA-induced gingival hyperplasia, i.e. various cytokine effects of inflammatory cells, existence of plaque or CsA itself, but its pathogenesis is still unclear. For experimental chronic CsA toxicity, salt depletion has been shown to increased susceptibility of rodents to the effects of CsA, and this maneuver facilitates production of arteriolopathy and interstitial fibrosis in kidney that mimic the changes found in human. The purpose of this study was to evaluate pathogenesis of CsA-induced gingival hyperplasia by comparing changes between CsA administration groups of normal standard diet and those of low salt diet group. Specific pathogen-free, 20 to 25 days old(120 to 150 g), male Fisher-344 rats(KIST, Korea), 120 to 150g of body weight, were assigned to four groups of six animals each after one week of adaptation period for powder food. Group 1 received olive oil($300{\mu}l/g\;of\;diet$) with normal standard diet(0.4% of sodium)(NSD). Group 2 received CsA(Cypol-N, Jonggundang, Korea; $300{\mu}g/g\;of\;diet$) with normal standard diet(NSD+CsA). Group 3 received same amount of olive oil with low salt diet(0.05 % of sodium, Teklad Premier, U.S.A.)(LSD). Group 4 received same dose of CsA with low salt diet(LSD+CsA). Rats were pair fed and were sacrificed after six weeks. Renal histologic lesions associated with CsA, consisted of cortical interstitial fibrosis, tubular atrophy and hyalinization of arterioles and the impairment of renal function including increase of serum creatinine and decrease of glomerular filtration rate was more severe in low salt diet group. These were proved as the results of activated of renin-angiotensin system in the kidney by low salt condition. Meanwhile the degree of gingival hyperplasia at incisor and molar tooth was less severe in low salt diet group compared with normal sodium diet group. Hyperplastic gingiva showed mild epithelial hyperplasia and expanded underlyng stroma which consisted of matrix increasement, capillary proliferation and dilatation. While the number and the activation of fibroblasts were increased, inflammatory cells were rare in the stroma. The immunohistochemistry for TGF-${\beta}_1$ in the kidney and gingiva revealed stronger positive in LSD+CsA in kidney but in gingiva of NSD+CsA. These results suggested followings; Gingival hyperplasia can be developed without inflammatory cells infiltration and seemed not induced by CsA by itself. The major role for gingival hyperplasia by CsA would be the secondary effect of TGF-${\beta}$, which maybe upregulated by CsA administration. Low salt diet can attenuate this hyperplasia perhaps by decreasing the activation of $TGF-{\beta}$.

  • PDF

중증 Henoch-$Sch{\ddot{o}}nlein$ Purpura Nephritis 환아에서 Cyclosporine A의 치료효과 (Therapeutic Effect of Cyclosporine A on Severe Henoch-$Sch{\ddot{o}}nlein$ Purpura Nephritis)

  • 진현종;김지홍;김병길;정현주
    • Childhood Kidney Diseases
    • /
    • 제2권2호
    • /
    • pp.110-117
    • /
    • 1998
  • 목 적 :신증후군을 동반한 Henoch-$Sch{\ddot{o}}nlein$ purpura nephritis는 예후가 좋지 않은 것으로 알려져 있으며 현재 스테로이드와 여러 면역억제제로 치료하고 있으나 정립된 고식적인 치료방법은 없다. Cyclosporine A는 잘 알려진 면역억제제로서 현재 신장 이식환자나 스테로이드에 반응하지 않는 사구체 질환에 많이 쓰이고 있다. 본 연구의 목적은 신증후군을 동반한 소아 Henoch-$Sch{\ddot{o}}nlein$ purpura nephritis환자에서 cyclosporine A(CsA)의 치료효과를 알아보고, 이미 보고된바 있는 rifampin(RFP)과 azathioprine(AZA)과의 치료효과를 비교하고자 함이다. 방 법 : 신장조직검사를 통해 확인된 총 37명의 신증후군을 동반한 Henoch-$Sch{\ddot{o}}nlein$ purpura nephritis환자가 이 연구에 포함되었으며, 이중 17명은 평균 6-8개월간 CsA(5 mg/kg/day)로, 7명은 9-12개월간 RFP(10-20 mg/kg/day)으로, 13명은 8개월간 AZA(2 mg/kg/day)으로 치료하였다. 모든 환자에서 저용량 경구 스테로이드(0.5-1 mg/kg, qod)를 함께 사용하였으며 치료 종결 후 모든 환자에서 1개월 후에 추적 신장조직검사를 시행하였다. 결 과 : 신증후군의 완전관해율은 평균 추적 관찰 기간 16, 21, 11개월 후 CsA group $58.8\%$, RFP group $57.1\%$, AZA group $38.4\%$이었고, 부분관해를 포함한 관해율은 CsA group $88.2\%$, RFP group $85.7\%$, AZA group $84.6\%$ 이었다. 혈뇨의 소실율은 CsA group $58.8\%$, RFP group $57.1\%$, AZA group $41.2\%$ 이었다. 임상상태의 호전을 보인 경우는 CsA group은 17명 중 17명, RFP group은 7명 중 7명, AZA group은 13명 중 10명이었다. 두 번의 신장조직검사를 통해 병리등급이 상향조정된 경우는 CsA group 5명($29.4\%$), RFP group 0명($0\%$), AZA group 2명($12.4\%$) 이었고, 면역형광검사 소견상 호전을 보인 경우는 CsA group 15명($88.2\%$), RFP group 6명($85.9\%$), AZA group 4명($30.8\%$) 이었다. 결 론 : 본 연구 결과, CsA는 RFP처럼 우수한 신증후군의 완전관해율을 보였으며, 면역형광 검사상에서도 의미있게 호전된 소견을 보이는 바(P=0.004) 아직 치료방법이 확립되지 않은 상황에서 CsA는 RFP과 더불어 신증후군이 동반된 심한 HSP 신염에서 추천할만한 약제로 사료된다.

  • PDF

Use of Antioxidants to Prevent Cyclosporine A Toxicity

  • Lee, Jin-Hwa
    • Toxicological Research
    • /
    • 제26권3호
    • /
    • pp.163-170
    • /
    • 2010
  • Cyclosporine A (CsA) is a potent immunosuppressor that is widely used in transplant surgery and the treatment of several autoimmune diseases. However, major side effects of CsA such as nephrotoxicity, hepatotoxicity, neurotoxicity and cardiovascular diseases have substantially limited its usage. Although molecular mechanisms underlying these adverse effects are not clearly understood, there is some evidence that suggests involvement of reactive oxygen species (ROS). In parallel, protective effects of various antioxidants have been demonstrated by many research groups. Extensive studies of CsA-induced nephrotoxcity have confirmed that the antioxidants can restore the damaged function and structure of kidney. Subsequently, there have appeared numerous reports to demonstrate the positive antioxidant effects on liver and other organ damages by CsA. It may be timely to review the ideas to envisage the relationship between ROS and the CsA-induced toxicity. This review is comprised of a brief description of the immunosuppressive action and the secondary effects of CsA, and a synopsis of reports regarding the antioxidant treatments against the ROS-linked CsA toxicity. A plethora of recent reports suggest that antioxidants can help reduce many CsA's adverse effects and therefore might help develop more effective CsA treatment regimens.

신장이식 후 Cyclosporine 혈중농도와 거부반응 및 신독성과의 관계 (The Relationship between Cyclosporine Trough Concentrations and Allograft Rejection and Renal Toxicity after Renal Transplantation)

  • 최수안;서옥경;이병구;손인자;신완균
    • 한국임상약학회지
    • /
    • 제13권1호
    • /
    • pp.1-4
    • /
    • 2003
  • Cyclosporine (CsA) has become well established as a potent immunosuppressive agent in the renal transplantation. However, therapy is complicated by large intraindividual and interindividual variability in pharmacokinetics of CsA and frequent undesirable clinical outcomes such as graft rejection and nephrotoxicity. The objective of this study was to determine the CsA trough blood concentrations that were associated with acute graft rejection and renal toxicity in renal transplant patients. Also, the ability of the current recommendation of therapeutic range for CsA to prevent graft rejections and CsA-associated renal toxicity was assessed. The clinical courses of the patients on CsA as an immusuppressive agent for preventing the graft rejection with renal ransplantation performed at Seoul National University Hospital from January 1995 to September 1998 were retrospectively reviewed. Total of 78 patients were included and three of them were retransplantation cases. Twenty-two acute episodes of rejection were identified, but only 16 episodes were clinically significant. Of these all the episodes occurred during the first month after transplantation except one. Mean daily doses of CsA were $427.2\pm72.1,\;352.6\pm56.8,\;308.62\pm48.3\;and\;268.47.1\;mg$ at posttransplant 1, 3, 6, and 12 months, respectively. Mean CsA whole blood though levels were $259.8\pm36.2,\;238.5\pm39,\;200.8\pm45.8\;and\;161.9\pm25.8\;ng/ml$ at posttransplant 1, 3, 6 and 12 months, respectively. Mean daily doses/weight were $7.9\pm1,\;6.4\pm1,\;5.3\pm0.7\;and\;4.6\pm0.7\;mg/kg$ at posttransplant 1, 3, 6 and 12 months, respectively. CsA doses decreased significantly as months progressed (p<0.001). During the first month after transplantation, only $12.5\%$ of the patients in rejection group had CsA concentration in therapeutic range, and 87.5, 93.8, and $100\%$ were within the therapeutic range at posttransplant 3, 6, and 12 months, respectively. These results suggested that CsA concentrations of $250\sim300\;ng/ml$ might be appropriate for preventing the acute rejection during the first posttransplant month.

  • PDF

Protective Effect of Right Ventricular Mitochondrial Damage by Cyclosporine A in Monocrotaline-induced Pulmonary Hypertension

  • Lee, Dong Seok;Jung, Yong Wook
    • Korean Circulation Journal
    • /
    • 제48권12호
    • /
    • pp.1135-1144
    • /
    • 2018
  • Background and Objectives: Mitochondria play a key role in the pathophysiology of heart failure and mitochondrial permeability transition pore (MPTP) play a critical role in cell death and a critical target for cardioprotection. The aim of this study was to evaluate the protective effects of cyclosporine A (CsA), one of MPTP blockers, and morphological changes of mitochondria and MPTP related proteins in monocrotaline (MCT) induced pulmonary arterial hypertension (PAH). Methods: Eight weeks old Sprague-Dawley rats were randomized to control, MCT (60 mg/kg) and MCT plus CsA (10 mg/kg/day) treatment groups. Four weeks later, right ventricular hypertrophy (RVH) and morphological changes of right ventricle (RV) were done. Western blot and reverse transcription polymerase chain reaction (RT-PCR) for MPTP related protein were performed. Results: In electron microscopy, CsA treatment prevented MCT-induced mitochondrial disruption of RV. RVH was significantly increased in MCT group compared to that of the controls but RVH was more increased with CsA treatment. Thickened medial wall thickness of pulmonary arteriole in PAH was not changed after CsA treatment. In western blot, caspase-3 was significantly increased in MCT group, and was attenuated in CsA treatment. There were no significant differences in voltage-dependent anion channel, adenine nucleotide translocator 1 and cyclophilin D expression in western blot and RT-PCR between the 3 groups. Conclusions: CsA reduces MCT induced RV mitochondrial damage. Although, MPTP blocking does not reverse pulmonary pathology, it may reduce RV dysfunction in PAH. The results suggest that it could serve as an adjunctive therapy to PAH treatment.